Valion Bio, Inc. SEC filings VBIO
Valion Bio, Inc. has 402 filings in SEC EDGAR's recent list, going back to Sep 10, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 16, 2026 | Nov 12, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 2, 2026 | Oct 2, 2026 |
| DEF 14A | Proxy statement | Jul 17, 2026 | Aug 14, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 7, 2026 | Aug 14, 2026 |
| DEF 14A | Proxy statement | Apr 30, 2026 | May 28, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 17, 2026 |
| DEFA14A | Additional proxy material | Feb 9, 2026 | — |
| DEF 14A | Proxy statement | Jan 9, 2026 | Jan 9, 2026 |
| PRE 14A | Preliminary proxy statement | Dec 29, 2025 | Dec 29, 2025 |
| DEF 14A | Proxy statement | Jun 2, 2025 | Jun 30, 2025 |
| PRE 14A | Preliminary proxy statement | May 23, 2025 | Jun 30, 2015 |
| DEF 14A | Proxy statement | Jan 3, 2025 | Jan 31, 2025 |
| PRE 14A | Preliminary proxy statement | Dec 23, 2024 | Jan 31, 2025 |
| DEFA14A | Additional proxy material | Jun 28, 2024 | — |
| DEF 14A | Proxy statement | Jun 28, 2024 | Jun 28, 2024 |
| DEFA14A | Additional proxy material | Jul 28, 2023 | — |
| DEF 14A | Proxy statement | Jul 24, 2023 | Aug 11, 2023 |
| PRE 14A | Preliminary proxy statement | Jul 13, 2023 | Aug 11, 2023 |
| DEFA14A | Additional proxy material | Jun 9, 2023 | — |
| DEFA14A | Additional proxy material | Apr 24, 2023 | — |
| DEF 14A | Proxy statement | Apr 24, 2023 | Jun 6, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2023 | Jun 6, 2023 |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 14, 2022 |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VBIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Antonio, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1787740
- Former names
- Tivic Health Systems, Inc. (until Apr 23, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.